0001596783-20-000185.txt : 20201009
0001596783-20-000185.hdr.sgml : 20201009
20201009152434
ACCESSION NUMBER: 0001596783-20-000185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201007
FILED AS OF DATE: 20201009
DATE AS OF CHANGE: 20201009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arnold Jonathan
CENTRAL INDEX KEY: 0001721336
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 201233102
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_160227145933929.xml
FORM 4
X0306
4
2020-10-07
0
0001596783
Catalent, Inc.
CTLT
0001721336
Arnold Jonathan
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
0
1
0
0
Pres. Oral & Specialty Deliv.
Common Stock
2020-10-07
4
M
0
11845
20.50
A
50463
D
Common Stock
2020-10-07
4
M
0
3680
31.96
A
54143
D
Common Stock
2020-10-07
4
M
0
8560
24.44
A
62703
D
Common Stock
2020-10-07
4
M
0
5877
36.02
A
68580
D
Common Stock
2020-10-07
4
M
0
2078
42.23
A
70658
D
Common Stock
2020-10-07
4
M
0
5144
43.88
A
75802
D
Common Stock
2020-10-07
4
M
0
2158
54.94
A
77960
D
Common Stock
2020-10-07
4
F
0
23414
91.50
D
54546
D
Common Stock
2020-10-07
4
S
0
15928
91.50
D
38618
D
Options to purchase Common Stock
20.5
2020-10-07
4
M
0
11845
0
D
2024-07-30
Common Stock
11845.0
0
D
Options to purchase Common Stock
31.96
2020-10-07
4
M
0
3680
0
D
2025-08-27
Common Stock
3680.0
0
D
Options to purchase Common Stock
24.44
2020-10-07
4
M
0
8560
0
D
2026-07-26
Common Stock
8560.0
0
D
Options to purchase Common Stock
36.02
2020-10-07
4
M
0
5877
0
D
2027-07-24
Common Stock
5877.0
1962
D
Options to purchase Common Stock
42.23
2020-10-07
4
M
0
2078
0
D
2027-10-04
Common Stock
2078.0
2081
D
Options to purchase Common Stock
43.88
2020-10-07
4
M
0
5144
0
D
2028-07-23
Common Stock
5144.0
5145
D
Options to purchase Common Stock
54.94
2020-10-07
4
M
0
2158
0
D
2029-07-22
Common Stock
2158.0
6476
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
Includes restricted stock units.
Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
Represents shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
On July 30, 2014, the reporting person was granted options to purchase 47,378 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on July 30, 2015.
On August 27, 2015, the reporting person was granted options to purchase 7,358 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on August 27, 2016.
On July 26, 2016, the reporting person was granted options to purchase 11,413 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on July 26, 2017.
On July 24, 2017, the reporting person was granted options to purchase 7,839 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on July 24, 2018.
On October 4, 2017, the reporting person was granted options to purchase 4,159 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on October 4, 2018.
The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.
The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.
/s/ Jose Ibietatorremendia, attorney-in-fact
2020-10-09